(Q40293504)

19 September 2017

title

Differential expression of caveolin-3 in mouse smooth muscle cells in vivo (English)

1 reference

19 September 2017

Hiroshi Kogo

1

1 reference

19 September 2017

Shin-ya Ito

2

1 reference

19 September 2017

Yoshinobu Moritoki

3

1 reference

19 September 2017

Hiroki Kurahashi

4

1 reference

19 September 2017

Toyoshi Fujimoto

5

1 reference

19 September 2017

publication date

28 January 2006

1 reference

19 September 2017

published in

Cell and Tissue Research

1 reference

19 September 2017

volume

324

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

291-300

1 reference

https://scigraph.springernature.com/pub.10.1007/s00441-005-0130-z

19 September 2017

exact match

0 references

cites work

Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

1 reference

https://api.crossref.org/works/10.1007%2FS00441-005-0130-Z

Caveolin-deficient mice: insights into caveolar function human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-005-0130-Z

Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-005-0130-Z

Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-005-0130-Z

Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-005-0130-Z

10.1007/S00441-005-0130-Z

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference